Fecal DNA testing for colorectal cancer screening and monitoring
Record ID 32007000381
English
Authors' objectives:
Fecal deoxyribonucleic acid (DNA) testing detects colorectal cancer (CRC) based on the presence of specific, cancer-associated mutations in DNA extracted from stool samples. Fecal DNA testing is intended as both a first-line screening test for CRC in asymptomatic individuals and as a monitoring tool in patients with known or suspected hereditary nonpolyposis colorectal cancer (HNPCC).
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2007
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=1904
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Colorectal Neoplasms
- DNA
- Feces
- Mass Screening
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.